Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy

Medicine and Dentistry

• Membranous Glomerulonephritis 80%
• Glomerulonephritis 80%
• Therapeutic Procedure 60%
• Rituximab 40%
• Plasmapheresis 40%
• Monoclonals 40%
• B Cell 40%
• Diseases 20%
• Antibody 20%
• Spontaneous Remission 20%
• Combination Therapy 20%
• Disease Process 20%
• Steroid 20%
• Autoimmune Disease 20%
• Glomerulus Basement Membrane 20%
• Cyclophosphamide 20%
• Chimeric Antibody 20%
• Targeted Therapy 20%

Immunology and Microbiology

• Glomerulus Basement Membrane 100%
• B Cell 40%
• Rituximab 40%
• Plasmapheresis 40%
• Monospecific Antibody 20%
• Autoimmune Disease 20%
• Antibody Titer 20%
• Cyclophosphamide 20%
• Chimeric Antibody 20%
• Anti-Glomerular Basement Membrane Antibody 20%